Clinical Trial Update: A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ILUVIEN (intravitreal fluocinolone acetonide) as baseline therapy for patients with early diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• ILUVIEN (fluocinolone acetonide)

Snippet

Sponsor: Alimera Sciences | Conditions: Diabetic Macular Edema | Phase 4 | Status: ACTIVE_NOT_RECRUITING